Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05635708 |
|---|---|
| Brief Title: | A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer |
| First Submitted : | November 23, 2022 |
| First Submitted that Met QC Criteria : | November 23, 2022 |
| First Posted : | December 2, 2022 |
| Last Update Submitted that Met QC Criteria : | April 24, 2024 |
| Last Update Posted : | April 25, 2024 |